Skip to content

NAMS

NewAmsterdam Pharma Co. NV

NASDAQ · Healthcare · Biotechnology · NL

$20.47
+3.23%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
55.58x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.88x
Price / sales
343.62x
Price / cash flow
-17.06x

Enterprise value

Enterprise value
$1.8B
EV / sales
254.62x
EV / EBITDA
-7.11x
EV / EBIT
-7.42x
Market cap
$2.4B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026